Global Pharma ..........Next Decade

Today morning was reading an article which said that there will be more demand for biological or rather biopharmaceutical compared to synthetic API in the coming decade. What I feel that there will be rise in the consumption of biological more in developed nations with respect to developing, emerging countries and third world nations and the big daddies will be acquiring many big generic giants in the emerging markets so that they can produce API's in cheaper rates. It is assumed that generic drug's market size is going to increase 8% annually.